Search results
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 1 day agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Better Buy: Inovio Pharmaceuticals vs. Novavax | The Motley Fool
The Motley Fool· 3 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of...
JP Morgan Upgrades Novavax, Inc. (NVAX) to a Neutral from an Underweight – Knox Daily
Knox Daily· 5 days agoNovavax, Inc.’s recently made public that its President, R&D Dubovsky Filip unloaded Company’s shares for reported $0.66 million on May 14 ’24. In the deal valued at $13.90 ...
Arbutus, Novavax See Activist Investor Action
Barrons.com· 19 hours agoShah had filed a May 6 proxy statement calling for shareholders to vote against the re-election of three directors. In the recent 13D amendment, filed on...
Novavax investor drops proxy battle in wake of big pharma deal - Washington Business Journal
The Business Journals· 5 days agoA Novavax Inc. shareholder that had been waging a campaign to oust three board members has withdrawn...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Novavax NVAX , and it's something market players shouldn't ignore. Our tracking of public ...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 6 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Shah Capital ends campaign against Novavax board after Sanofi deal
Reuters via AOL· 5 days agoUnder a deal signed on May 10, the French drugmaker will take a 4.9% stake in Novavax for $70...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 1 day agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
